Zinc sulphate: A reasonable choice for depression management in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial

Double Blind ◽

Double Blind Placebo ◽

Depression Management ◽

Reasonable Choice

Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial.

Journal of Neurology Neurosurgery & Psychiatry ◽

10.1136/jnnp.57.suppl.11 ◽

1994 ◽

Vol 57 (Suppl) ◽

pp. 11-14 ◽

Cited By ~ 19

Author(s):

J H Noseworthy ◽

P C O'Brien ◽

B G van Engelen ◽

M Rodriguez

Keyword(s):

Multiple Sclerosis ◽

Clinical Trial ◽

Intravenous Immunoglobulin ◽

Immunoglobulin Therapy ◽

Theiler's Virus ◽

Double Blind ◽

Intravenous Immunoglobulin Therapy ◽

Double Blind Placebo ◽

Virus Model

Effects of 4-aminopyridine on attention and executive functions of patients with multiple sclerosis: Randomized, double-blind, placebo-controlled clinical trial. Preliminary report.

Multiple Sclerosis and Related Disorders ◽

10.1016/j.msard.2018.12.026 ◽

2019 ◽

Vol 28 ◽

pp. 117-124 ◽

Cited By ~ 2

Author(s):

C. Arreola-Mora ◽

J. Silva-Pereyra ◽

T. Fernández ◽

M. Paredes-Cruz ◽

B. Bertado-Cortés ◽

...

Keyword(s):

Multiple Sclerosis ◽

Clinical Trial ◽

Executive Functions ◽

Preliminary Report ◽

Double Blind ◽

Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatment

European Journal of Neurology ◽

10.1111/j.1468-1331.2006.01533.x ◽

2006 ◽

Vol 13 (8) ◽

pp. 887-895 ◽

Cited By ~ 91

Author(s):

K. G. Warren ◽

I. Catz ◽

L. Z. Ferenczi ◽

M. J. Krantz

Keyword(s):

Multiple Sclerosis ◽

Clinical Trial ◽

Disease Progression ◽

Synthetic Peptide ◽

Progressive Multiple Sclerosis ◽

Hla Class Ii ◽

Double Blind ◽

Short-Term Effect of High-Dose Vitamin D on the Level of Interleukin 10 in Patients with Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

NeuroImmunoModulation ◽

10.1159/000439278 ◽

2015 ◽

Vol 22 (6) ◽

pp. 400-404 ◽

Cited By ~ 26

Author(s):

Fereshteh Ashtari ◽

Nafiseh Toghianifar ◽

Sayyed Hamid Zarkesh-Esfahani ◽

Marjan Mansourian

Keyword(s):

Multiple Sclerosis ◽

Clinical Trial ◽

Interleukin 10 ◽

Term Effect ◽

High Dose ◽

Short Term ◽

Double Blind ◽

Double Blind Placebo ◽

High Dose Vitamin

Effect of high dose vitamin D intake on interleukin-17 levels in multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial

Journal of Neuroimmunology ◽

10.1016/j.jneuroim.2015.05.022 ◽

2015 ◽

Vol 285 ◽

pp. 125-128 ◽

Cited By ~ 29

Author(s):

Nafiseh Toghianifar ◽

Fereshteh Ashtari ◽

Sayyed Hamid Zarkesh-Esfahani ◽

Marjan Mansourian

Keyword(s):

Multiple Sclerosis ◽

Clinical Trial ◽

Vitamin D ◽

High Dose ◽

Interleukin 17 ◽

Double Blind ◽

Double Blind Placebo ◽

Vitamin D Intake ◽

High Dose Vitamin

Faculty Opinions recommendation of Effect of high dose vitamin D intake on interleukin-17 levels in multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725665992.793521853 ◽

2016 ◽

Author(s):

Frank Lammert

Keyword(s):

Multiple Sclerosis ◽

Clinical Trial ◽

Vitamin D ◽

High Dose ◽

Interleukin 17 ◽

Double Blind ◽

Double Blind Placebo ◽

Vitamin D Intake ◽

High Dose Vitamin

The therapeutic effect of PEGlated nanoliposome of pistachio unsaturated oils and its efficacy to attenuate inflammation in multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial phase I

Journal of Neuroimmunology ◽

10.1016/j.jneuroim.2021.577768 ◽

2021 ◽

pp. 577768

Author(s):

Gholamhossein Hassanshahi ◽

Mojgan Noroozi Karimabad ◽

Ali Jebali

Keyword(s):

Multiple Sclerosis ◽

Clinical Trial ◽

Phase I ◽

Therapeutic Effect ◽

Double Blind ◽

Double Blind Placebo ◽

Trial Phase

Test 1: Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial

Gene ◽

10.1016/s0378-1119(15)30104-4 ◽

2015 ◽

Author(s):

Jerry Lewis ◽

Lauren Bacall ◽

Humphrey Bogart ◽

Gene Kelly

Keyword(s):

Clinical Trial ◽

Double Blind ◽

Double blind placebo controlled clinical trial of homoeopathic medicines in HIV infection

British Homeopathic Journal ◽

10.1038/sj.bhj.5800206 ◽

1998 ◽

Vol 87 (2) ◽

pp. 86-88

Author(s):

D P Rastogi ◽

V P Singh ◽

Vikram Singh ◽

S K Dey ◽

K Rao

Keyword(s):

Clinical Trial ◽

Hiv Infection ◽

Double Blind ◽

A Magnetic Resonance Spectroscopy Study of Lovastatin for Treating Bipolar Mood Disorder: A 4-Week Randomized Double-Blind, Placebo- Controlled Clinical Trial

Recent Patents on Inflammation & Allergy Drug Discovery ◽

10.2174/1872213x10666161028153258 ◽

2017 ◽

Vol 10 (2) ◽

pp. 133-141 ◽

Cited By ~ 2

Author(s):

Mehrzad Lotfi ◽

Sara Shafiee ◽

Ahmd Ghanizadeh ◽

Motahar O. Sigaroudi ◽

Leila Razeghian

Keyword(s):

Clinical Trial ◽

Magnetic Resonance ◽

Magnetic Resonance Spectroscopy ◽

Resonance Spectroscopy ◽

Spectroscopy Study ◽

Double Blind ◽

Double Blind Placebo ◽

Magnetic Resonance Spectroscopy Study ◽

Bipolar Mood Disorder